The global animal model market is witnessing significant growth, driven by advancements in biomedical research, increasing demand for preclinical testing, and expanding applications in drug discovery and development. In 2022, the market size was estimated at USD 2.2 billion, and it is expected to reach USD 4.2 billion by 2030, demonstrating a robust Compound Annual Growth Rate (CAGR) of 8.7% during the forecast period of 2023-2030.Animal models, including mice, rats, rabbits, and non-human primates, play a crucial role in biomedical research and drug development by providing insights into disease mechanisms, evaluating drug efficacy and safety, and modeling human physiological and pathological conditions. Key factors driving the growth of the animal model market include:
Get Sample PDF @ https://www.snsinsider.com/sample-request/3789
Key Players
The major key players are Charles River Laboratories, The Jackson Laboratory, genOway, Taconic Biosciences, Inc., Janvier Labs, Harbour BioMed, Crown Bioscience, Inotiv, BIOCYTOGEN, BioSpherix, Ltd., and Others
Advancements in Biomedical Research: Animal models are indispensable tools for studying complex biological processes, modeling human diseases, and testing novel therapeutic interventions. Ongoing advancements in genetic engineering, imaging technologies, and molecular biology techniques have enhanced the utility and versatility of animal models, driving demand for genetically modified and disease-specific animal models for research purposes.
Increasing Demand for Preclinical Testing: Pharmaceutical companies, biotechnology firms, and academic research institutions rely on animal models for conducting preclinical studies to assess the safety, efficacy, and pharmacokinetics of drug candidates before initiating clinical trials. Animal models provide valuable data on drug metabolism, toxicology, and pharmacodynamics, enabling informed decision-making in drug development and regulatory approval processes.
Expanding Applications in Drug Discovery and Development: Animal models are integral to the drug discovery and development pipeline, from target identification and validation to lead optimization and preclinical testing. Animal models are used to study a wide range of therapeutic areas, including oncology, neurology, cardiovascular diseases, and metabolic disorders, driving market growth and innovation in drug research and development.
Focus on Translational Medicine and Precision Oncology: There is a growing emphasis on translational medicine approaches that bridge the gap between preclinical research and clinical practice, with a focus on developing more predictive and clinically relevant animal models. Additionally, advancements in precision oncology and personalized medicine drive the demand for genetically engineered animal models and patient-derived xenograft models for studying tumor biology and therapeutic responses, driving market expansion in oncology research.
KEY SEGMENTS
By Type
Mice
Rat
Guinea Pigs
Rabbits
Hamsters
Others
By Application
Cancer
Immunological Disease
Infectious Disease
Others
By End User
Pharmaceutical & Biotechnology Companies
Academic Research Institute
Contract Research Organization
As the animal model market continues to evolve, stakeholders across the biomedical research, pharmaceutical, and biotechnology industries are leveraging animal models to accelerate scientific discoveries, improve drug development outcomes, and address unmet medical needs. With a focus on ethical and humane use of animals in research, regulatory compliance, and scientific rigor, the animal model market is poised for sustained growth and innovation in the coming years.
Other Tending Report
Immunohistochemistry Market Share
Viral Vectors and Plasmid DNA Manufacturing Market Share
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Akash Anand – Head of Business Development & Strategy
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
Website: https://www.snsinsider.com
